Cancer: NICE (symptom based)- what s new November 2016

Size: px
Start display at page:

Download "Cancer: NICE (symptom based)- what s new November 2016"

Transcription

1 Cancer: NICE (symptom based)- what s new November 2016 Dr Katy Gardner, Dr Cathy Hubbert, Macmillan GP Cancer Leads, Liverpool CCG See stalls for more information and local pathways (Cheshire & Merseyside)

2 COULD IT BE CANCER? Now 3% threshold

3 HISTORY AND EXAM INVESTIGATE REFER REVIEW SAFETY NET

4 SYMPTOMS: NICE recognises that: Patients present with symptoms /signs or combinations: BMJ /CRUK charts

5 Non site specific symptoms of concern: WEIGHT LOSS: many cancers APPETITE LOSS: remember lung and ovary DVT is back! Several cancers include: urogenital, breast, colorectal, lung, pancreas FATIGUE: FBC, Ca125, CXR -(40+ ever smoked/ asbestos)

6 INVESTIGATIONS: some highlights FBC for PLATELETS, WBC, ANAEMIA IRON STUDIES ELECTROPHORESIS and BJP Ca 125 CALCIUM (myeloma) GLUCOSE ( pancreas, endometrial) ULTRASOUND/CT URINE visible/non visible haematuria *Recurrent infection can be significant

7 RAISED PLATELETS: in up to 30% of some cancers: Lung: >40 consider CXR Upper GI: >55 naus/vom/wt loss/ dyspepsia/abd pain: consider OGD Endometrial: >55 haematuria/vag disch: consider US Consider age/other risks

8 Iron Deficiency Anaemia (IDA) New importance in NICE.. No cut-off threshold 60+ IDA: Refer 2ww <50 IDA + rectal bleeding: consider ref to lower GI >55 anaemia +abdo pain: consider OGD (upper GI cancer)

9 Ix for Myeloma Persistent bone pain: esp back pain, or unexplained fracture: do FBC, ESR, Ca 60+ with hypercalcaemia/ WBC: do electrophoresis and BJP within 48hr As well as myeloma think about bony secondaries

10 When to check CA125 (Females) Abdo/pelvic pain/distention (persistent) age 50 IBS symptoms age 50 Change in bowel symptoms Urine urgency (persistent) age 50 Examine patient! NICE: Do CA125/US BUT locally: do Ca125 first: If Ca125, arrange US abdo/pelvis: mark URGENT suspected ovarian cancer. Put CA125 result on form. Will have US within 2 weeks

11 When to request US CONSIDER -Routine: F 55, Vaginal discharge (new/ platelets/haematuria (endometrial) F 55 haematuria + anaemia or platelets or glucose (endomterial) (AS WELL AS 2ww urology if visible haematiuria) M Unexplained or persistent testicular symptoms (BUT possible urgent!) URGENT: unexplained lump increasing in size (sarcoma)

12 When to request urgent CXR OFFER: 40 ever smoked +1 unexplained symptom (2 if never smoked): Cough, fatigue, SOB, chest pain, weight loss, appetite loss Asbestos exposure + 1 of above CONSIDER: >40 persistent/ recurrent chest infection, finger clubbing, LN: supraclavicular or cervical, pleural disease, thrombocytosis (Suspicious CXR: straight to CT pathway in Liverpool )

13 When to request urgent OGD Dysphagia 55 + weight loss + one of : Upper abdominal pain/ reflux/ dyspepsia CONSIDER if Upper abdominal mass consistent with stomach cancer (BUT consider CT ) See stalls for local pathways

14 When to arrange routine OGD CONSIDER if >55 and: Dyspepsia: treatment resistant Anaemia (normo/micro) + upper abdominal pain Nausea or vomiting + any of: weight loss /reflux/dyspepsia/upper abdo pain Raised platelets + naus vom wt loss /reflux/dyspepsia/upper abdo pain Hematemesis (use clinical judgment!)

15 When to request urgent CT: (think pancreas) CONSIDER: 60 + weight loss + one of: diarrhoea, constipation, back pain, abdominal pain, nausea, vomiting, new onset diabetes. Straight to CT pathways at Aintree & RLBUHT- and St Helens and Knowsley (for weight loss/ vague symptoms that don t fit 2ww see handout)

16 Faecal Occult Blood FOB in NICE for: 50 unexplained abdo pain or weight loss < 60 change in bowel habit or IDA >60 with anaemia not nec IDA BUT may not be available locally -debate ongoing. So what can we do? Examine / do bloods. IDA -- to IDA clinic if available or colorectal Wt loss - see CT or does any other pathway fit? If you think FOB and sx don t fit other urgent pathways-consider 2 ww GI referral.

17 Weight loss (recap) plus: Ever smoked/ h/o asbestos- cough/ fatigue/ SOB / chest pain/ appetite loss- CXR Abdo pain/ rectal bleeding- lower GI Upper abdo pain/ reflux/ dyspepsia or raised platelets/ nausea/ vomit- OGD Diarrhoea/ abdo/ back pain/ n/ v/ constipation/ new onset DM- CT Splenomegaly/ lymphadenopathy- Haematology F esp 50+ Ca125- ovarian

18 Fatigue (recap) plus: 40 or > Ever smoked/h/o asbestos/ cogh/ weight loss/sob/ chest pain/ appetite loss CXR* Persistent unexplained and age FBC within 48 hrs F 50 or > wt loss, change in bowel habit- Ca 125 Remember to examine the patient! *can be normal in up to 20% lung Ca think CT

19 Children & Young Adults Refer within 48 hr: Abdo mass /enlarged abdo organ/ unexplained visible haematuria Refer within 2w: absent red reflex FBC (48h): unexplained bruising/bleeding/pallor/lymphadenopathy/ fever/ infection/ fatigue US (48h): lump unexplained/ increasing X ray (48h): bone pain/ swelling Consider Parental concern 19

20 Tumour Specific Pathways Most = broader e.g Colorectal o 50y: unexplained rectal bleed o 40y: weight loss and abdo pain Clinical judgement key encourage GPs to refer, consider, investigate Controversial: ENT clinicians keep persistent sore throat etc. and remember HPV Some Oral lesions advises dentist but not all have one so refer 2ry care

21 Tumour Specific Pathways Useful Tools -worth CPD time to familiarise and know where to look! Eg Macmillan, GP Update, BMJ/CRUK charts GP UpdateCancer course

22

23 NICE emphasises Communicate: Patient preferences Potential risk and benefits Explain: referred to cancer service (but most referred do not have cancer) Inform on possible diagnosis (benign & malignant) Where, when, what, who? Further information/written, support, language Patient friendly letter/ CRUK leaflet (see stalls)

24 NICE emphasises: Safetynet Responsibility for reviewing/acting on results of investigation. Keep pt under review Or: Explicitly pass on responsibility. Awareness false negatives (CXR and FOB) New symptom, patient concerned, recurs, persists or worsens. HAVE YOU GOT FIALSAFE SYSTESM IN PLACE?

25 LOCAL INITIATIVES include Colorectal Clinics AO advice pilot Direct to CT Brain MRI Ovarian 50+ pathway See stalls! Ask CRUK team

26 Acute Oncology- Is it Cancer? advice see stalls for full algorithm

27 Direct to CT Aintree/ RLBUHT(similar New NICE Plus Patient has symptoms which give GP high index of suspicion of cancer but History/examine/ usual investigations don t fit 2ww.. Any age pathway Whitson) See Handouts. NB on local Trusts

28 Brain -Direct to MR coming soon Adults with progressive, sub-acute loss of CNS function* NICE says do MRI New referral forms for Walton Neuro being prepared. (Criteria/contraindications: see CCG websites) *Now: If Direct MRI not available refer 2ww or ring Walton helpline (available through switchboard)

29 Ovarian pathway: F age 50+ Cheshire and Merseyside-see stalls

30 Risk assessment tools: (Macmillan/Qcancer. Now in Emis) For common cancers: Estimates lifetime risk of cancer Based on multiple risk factors *Does not align perfectly with NICE Down to clinical judgements/patient preferences We feel: Useful if person presents with symptoms and you are thinking cancer

31 Do 3 things! Examples 1. Safety-netting: ensure systems in place 2. RCGP/national cancer audit 3. SEA:

32 For more information contact your primary care cancer team : Dr Katy Gardner katyagardner@btinternet.com Dr Cathy Hubbert cathy.hubbert@livgp.nhs.uk Dr Debbie Harvey Debbie.Harvey@southseftonccg.nhs.uk Dr Paul Morris Paul.Morris@knowsleyccg.nhs.uk Dr Graeme Allan graeme.allan@talk21.com Dr Hong Tseung hong.tseung@nhs.net Tomas Edge (CRUK) tomas.edge@cancer.org.uk Louise Roberts (CRUK) louise.roberts@cancer.org.uk

Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives

Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives Dr. Louise Merriman GP Clinical Lead for South Yorkshire, Bassetlaw and Derbyshire Cancer Alliance Topics to be covered

More information

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature.

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature. July 2015 edition Introduction The Rapid Referral guidance toolkit has been produced by Macmillan Cancer Support. It contains the NICE referral guidelines for suspected cancer (2015 update) with additional

More information

Achieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018

Achieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018 Achieving earlier diagnosis of cancer in Lincolnshire Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018 The state of Lincolnshire Cancer Care Lincolnshire: The worst part of the country

More information

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training

More information

FIT for symptomatic patients. Facilitator name

FIT for symptomatic patients. Facilitator name FIT for symptomatic patients Facilitator name Context colorectal cancer Colorectal cancer in the UK 41,804 new cases in 2015 15,903 deaths in 2014 Fourth most common cancer Second most common cause of

More information

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 GP INTIATIED DIAGNOSITCS USS Gall Bladder or Liver Fast-track ultrasound to assess for gall bladder or liver

More information

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous

More information

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 Dr Peter Hutchison, Chair of Review Group WHAT & WHY? Scottish Cancer Referral Guidelines 2014 Scottish Primary Care Cancer Group identified need for some

More information

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres Greater Manchester Commissioning Hub: Cancer Programme The ACE Programme Wave 2 Multidisciplinary Diagnostic Centres Background / Context GM Pilot focuses on 2 areas of Greater Manchester: Oldham South

More information

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West The South West Cancer Alliances have been awarded transformation funding to provide access to

More information

Cancer Care Kenya Notes for General Practioners:

Cancer Care Kenya Notes for General Practioners: Cancer Care Kenya Notes for General Practioners: Site specific symptoms for detecting cancers at an early stage is given below. Please refer patients for detailed work up. 1. Brain /CNS tumors: Sub acute

More information

Haematological Cancer Suspected (Adults & Children)

Haematological Cancer Suspected (Adults & Children) Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years

More information

Qcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd

Qcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd + Qcancer: symptom based approach to early diagnosis of cancer Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd Acknowledgements Co-authors QResearch database EMIS & contributing

More information

Cancer of Unknown Primary Service

Cancer of Unknown Primary Service Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT

More information

Lung Cancer - Suspected

Lung Cancer - Suspected Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding

More information

FREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430

FREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430 Freedom of Information Team Dudley CCG Response by email 2nd Floor, Brierley Hill Health and Social Care Centre Venture Way Brierley Hill DY5 1RU 26 May 2016 FREEDOM OF INFMATION ACT 2000 Dudley CCG -

More information

Clinical Biochemistry Department City Hospital

Clinical Biochemistry Department City Hospital Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs

More information

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Update on Management of Malignant Spinal Cord Compression Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Current Guidelines The symptoms of MSCC may be subtle and therefore careful

More information

This information explains the advice about suspected cancer that is set out in NICE guideline NG12.

This information explains the advice about suspected cancer that is set out in NICE guideline NG12. Recognising, investigating and referring people with symptoms of suspected cancer Information for the public Published: 25 June 2015 nice.org.uk About this information NICE guidelines provide advice on

More information

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM PRIORITIES AND CLINICAL EFFECTIVENESS FORUM CANCER - GUIDELINES FOR URGENT REFERRAL OF PATIENTS WITH These guidelines are intended as a quick reference for GPs to ensure appropriate referral of those patients

More information

Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance

Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance FIT for symptomatic patients Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance AIMS Review National advice Consider

More information

Transforming Cancer Services for London

Transforming Cancer Services for London Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection

More information

Bronchiectasis in Adults - Suspected

Bronchiectasis in Adults - Suspected Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors

More information

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012

GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 GP Guidelines for the Management of Adult Patients with Gynaecological Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt of a new version. Date

More information

Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis

Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis BMJ 2010;340:c1269 doi:10.1136/bmj.c1269 Mr DC 62 year old man Borderline anaemia

More information

Information for families with a slightly increased risk of bowel cancer. Family History of Bowel Cancer

Information for families with a slightly increased risk of bowel cancer. Family History of Bowel Cancer Information for families with a slightly increased risk of bowel cancer Family History of Bowel Cancer How common is bowel cancer? Bowel cancer is the 3rd most common cancer in the UK. 1 in 20 people develop

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Lung Cancer and the Cancer Alliance DR JAMES RAMSAY

Lung Cancer and the Cancer Alliance DR JAMES RAMSAY Lung Cancer and the Cancer Alliance DR JAMES RAMSAY Background Lung cancer is the second commonest cancer in the UK (37,000 new cases in England each year). Commonest cause of cancer death (28,500 people

More information

Palliative Care Emergencies

Palliative Care Emergencies Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena

More information

South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance

South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance Patient Details: Patient Name Address DOB Home Tel. No. Mobile Tel. No. Preferred Tel. No. Main Spoken Language Transport needed? Registered

More information

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill The York Faecal Calprotectin Care Pathway for use in primary care James Turvill NICE guidance: dg11 Faecal calprotectin (FC) testing as an option in adults with recent onset of lower gastrointestinal symptoms

More information

Cancer Cascade Workshop. DoubleTree by Hilton, Bristol 11 th May 2017

Cancer Cascade Workshop. DoubleTree by Hilton, Bristol 11 th May 2017 DoubleTree by Hilton, Bristol 11 th May 2017 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK What s new? Cancer Cascade Workshop What s

More information

There are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.

There are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway. December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification

More information

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:... Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -

More information

West Midlands Sarcoma Advisory Group

West Midlands Sarcoma Advisory Group West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary

More information

Early Diagnosis: Serious but non-specific symptom pathway

Early Diagnosis: Serious but non-specific symptom pathway Early Diagnosis: Serious but non-specific symptom pathway Lily Megaw Becky Gokce Karen Fitzgerald Geraint Jones Luigi de Michele Arun Takhar Introduction Lily Megaw This is a five year programme Based

More information

THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION

THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION Dr Jennifer Yiallouros RCGP and CRUK workshop Brighton, March 2017 Acknowledgements Thames Valley Strategic Clinical

More information

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist Gynaecological cancers Why do we need 2 week wait? Early/timely diagnosis of cancer Possibly less invasive treatment and

More information

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography 2019 Released 2019 health.govt.nz Citation: Ministry of Health. 2019. Referral Criteria for Direct Access

More information

Urgent referral for suspected cancer in Scotland

Urgent referral for suspected cancer in Scotland 270 Oncology Urgent referral for suspected cancer in Scotland Cancer is a common problem, but an individual GP may only see about seven to eight new cases of cancer per annum (although they will see many

More information

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS Hull & East Riding Prescribing Committee Prescribing Framework for Methotrexate for Immunosuppression in ADULTS Patient s Name:.. NHS Number: Patient s Address:... (Use addressograph sticker) GP s Name:...

More information

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Prevention of Bowel Cancer: which patients do I send for colonoscopy? Prevention of Bowel Cancer: which patients do I send for colonoscopy? Dr Chris Groves Consultant Gastroenterologist and Honorary Senior Lecturer St George s Hospital and Medical School Director, SW London

More information

Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway

Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway Version 2: May 2012 To be read in conjunction with NICE CG75 Developed by consensus by: Dr Peter Robson, Consultant Oncologist,

More information

Information for people without an increased risk of bowel cancer. Family History of Bowel Cancer

Information for people without an increased risk of bowel cancer. Family History of Bowel Cancer Information for people without an increased risk of bowel cancer Family History of Bowel Cancer Bowel cancer in the family what does this mean for me? Bowel cancer is a fairly common type of cancer. Many

More information

Cancer. University of Illinois at Chicago College of Nursing

Cancer. University of Illinois at Chicago College of Nursing Cancer University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Develop a basic understanding of cancer 2. Describe

More information

Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms

Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms Interim report May 2018 Version 2.4 Accelerate, Coordinate, Evaluate (ACE) Programme An early

More information

Pancreatic Cancer. Stats, facts and how things can improve. Let s drive earlier diagnosis

Pancreatic Cancer. Stats, facts and how things can improve. Let s drive earlier diagnosis Pancreatic Cancer Stats, facts and how things can improve Ali Stunt, Founder & Chief Executive Pancreatic Cancer Action (and 8 year survivor of pancreatic cancer) Let s drive earlier diagnosis The Pancreas

More information

Vinorelbine (Oral) Oral Vinorelbine

Vinorelbine (Oral) Oral Vinorelbine Oral Vinorelbine Vinorelbine (Oral) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming

More information

Rapid referral toolkit

Rapid referral toolkit Menu Introduction and help Cancer types and contacts Cancer services team Rapid referral toolkit Macmillan resources Acknowledgements www.macmillan.org.uk Macmillan Cancer Support, registered charity in

More information

FLU CLINICS 2012 This year, the surgery will be opening on Saturday 13 TH and 20 th October PLEASE NOTE:

FLU CLINICS 2012 This year, the surgery will be opening on Saturday 13 TH and 20 th October PLEASE NOTE: GOODBYE Vicky one of our Receptionist s, who has now left us, we wish her luck in the future and hope she enjoys her new position in Helsby. FLU CLINICS 2012 This year, the surgery will be opening on Saturday

More information

Referral guidelines for suspected cancer

Referral guidelines for suspected cancer Referral guidelines for suspected cancer NICE guideline Second draft for consultation, September 2004 If you wish to comment on the recommendations, please make your comments on the full version of the

More information

A patient s guide to understanding. Cancer. Screening

A patient s guide to understanding. Cancer. Screening A patient s guide to understanding Cancer Screening Contents 04 06 10 12 Cancer Screening Who Should Go For Cancer Screening 05 Nasopharyngeal Carcinoma Colorectal Cancer 08 Lung Cancer Liver Cancer Breast

More information

Pancreatic Cancer. An overview for GPs. Let s drive earlier diagnosis. Pancreatic Cancer Action All Rights Reserved

Pancreatic Cancer. An overview for GPs. Let s drive earlier diagnosis. Pancreatic Cancer Action All Rights Reserved Pancreatic Cancer An overview for GPs Pancreatic Cancer Action All Rights Reserved Pancreatic Cancer Action is a UK charity Registration no 1137689 Let s drive earlier diagnosis The Pancreas This image

More information

When to Refer for OGD and the Work Up of Upper GI Malignancies

When to Refer for OGD and the Work Up of Upper GI Malignancies When to Refer for OGD and the Work Up of Upper GI Malignancies Dr Hong Qiantai Registrar, Department of Surgery GP Forum 27 May 2017 38 year old female, non-smoker, BMI 29 Works as investment banker Presents

More information

Brain and Central Nervous System Cancers

Brain and Central Nervous System Cancers Brain and Central Nervous System Cancers NICE guidance link: https://www.nice.org.uk/guidance/ta121 Clinical presentation of brain tumours History and Examination Consider immediate referral Management

More information

1. What is fulvestrant?

1. What is fulvestrant? Talk to our breast care nurses 0808 800 6000 1. What is fulvestrant? 2. How does fulvestrant work? 3. When might fulvestrant be prescribed? 4. How is fulvestrant given? 5. How long will I be given fulvestrant

More information

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients

More information

6 UROLOGICAL CANCERS. 6.1 Key Points

6 UROLOGICAL CANCERS. 6.1 Key Points 6 UROLOGICAL CANCERS 6.1 Key Points Prostate Cancer Commonest cancer in males in Scotland Approximately 99% of cases occur in men aged > 50 years About 40% of cases present in men aged < 70 years when

More information

SOME USEFUL THINGS TO KNOW ABOUT HEAD AND NECK CANCER IN 2016

SOME USEFUL THINGS TO KNOW ABOUT HEAD AND NECK CANCER IN 2016 SOME USEFUL THINGS TO KNOW ABOUT HEAD AND NECK CANCER IN 2016 Ann Dingle Mid Cheshire Hospitals ENT Surgeon in a DGH with an interest in Head and Neck disease Cancer Lead Plan for today Facts and figures

More information

Healthcare Improvement Scotland First published May 2014

Healthcare Improvement Scotland First published May 2014 Scottish referral guidelines for suspected cancer: gynaecological; haematological; head and neck; brain and central nervous system; sarcomas and bone; children, teenagers and young adult cancers; and malignant

More information

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session Childhood Cancer Dr Sarah Taaffe Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session What I plan to cover in this session Background- Why this topic.. What types of cancer

More information

Dr Greg Frazer. Respiratory Physician Christchurch Hospital Christchurch. 15:10-15:35 Primary and Secondary Healthcare Interface Supported by:

Dr Greg Frazer. Respiratory Physician Christchurch Hospital Christchurch. 15:10-15:35 Primary and Secondary Healthcare Interface Supported by: Dr Greg Frazer Respiratory Physician Christchurch Hospital Christchurch 15:10-15:35 Primary and Secondary Healthcare Interface Supported by: Primary and Secondary Healthcare Interface How Working Together

More information

Leeds: Early Diagnosis Project updates

Leeds: Early Diagnosis Project updates Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy

More information

Information leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)

Information leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC) Information leaflet for women with an increased lifetime risk of breast and ovarian cancer Hereditary Breast and Ovarian Cancer (HBOC) What is Hereditary Breast and Ovarian Cancer (HBOC)? Hereditary Breast

More information

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017

Gynaecology Cancer Red Flags. Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017 Gynaecology Cancer Red Flags Dr Dina Bisson Consultant Obstetrician and Gynaecologist Southmead Hospital North Bristol NHS Trust 27 April 2017 Gynaecological Cancers Endometrial Cancer Ovarian Cancer Cervical

More information

Referral guidelines for suspected cancer

Referral guidelines for suspected cancer Quick reference guide Issue date: June 2005 Referral guidelines for suspected cancer Clinical Guideline 27 Developed by the National Collaborating Centre for Primary Care Ordering information Copies of

More information

Improving diagnostic pathways for patients with vague symptoms

Improving diagnostic pathways for patients with vague symptoms Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer

More information

Gemcitabine and Cisplatin (urology)

Gemcitabine and Cisplatin (urology) Gemcitabine and Cisplatin Gemcitabine and Cisplatin (urology) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce

More information

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed

More information

9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups

9/13/2017. Highgate Private Hospital & Whittington Health NHS Trust. London Cancer Urology Guidelines for Target Referrals. Urological Cancer Groups London Cancer Urology Guidelines for Target Referrals Mr Paul Erotocritou MBBS BSc MSc, MRCS, FRCS (Urol)Eng Highgate Private Hospital & Whittington Health NHS Trust Urological Cancer Groups 5 groups:

More information

GI cancer. Sharan Pobbathi Rumina Önaç

GI cancer. Sharan Pobbathi Rumina Önaç GI cancer Sharan Pobbathi Rumina Önaç Why is this relevant? One new case per year per GP York slightly below national average Contents/objectives To know the 2ww criteria and where to find them To be aware

More information

Philippine Cancer Society Forum: Cancer can be cured!

Philippine Cancer Society Forum: Cancer can be cured! Philippine Cancer Society Forum: Cancer can be cured! Throughout history, doctors and scientists have extensively studied Their researchers have not only yielded a wealth of information on the disease,

More information

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma

More information

No. 2 - Persistent Pain or Discomfort in Any Body Area

No. 2 - Persistent Pain or Discomfort in Any Body Area See Your Doctor When Symptoms Occur, and Get Regular Checkups. Experts say that men could benefit greatly by being alert to certain cancer symptoms that indicate a trip to the doctor's office sooner rather

More information

SIGNS, SYMPTOMS AND SCREENING GUIDELINES

SIGNS, SYMPTOMS AND SCREENING GUIDELINES SIGNS, SYMPTOMS AND SCREENING GUIDELINES SIGNS AND SYMPTOMS You may think it s normal, but it could be a sign or symptom of an illness or cancer-related disease. If you are experiencing any of these signs

More information

Alectinib (Alecensa ) Alectinib (Alecensa )

Alectinib (Alecensa ) Alectinib (Alecensa ) Alectinib (Alecensa ) Alectinib (Alecensa ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people, treatment may reduce the risk of the cancer

More information

NICE Guidance. Suspected Cancer in Adults COLORECTAL (2WW)

NICE Guidance. Suspected Cancer in Adults COLORECTAL (2WW) NICE Guidance Suspected Cancer in Adults COLORECTAL (2WW) Date of Referral: Short date letter merged Name: Full Name DOB: Date of Birth NHS No NHS Number Attach this form to the e-referral within 24 hours

More information

Cancer Facts for People Over 50

Cancer Facts for People Over 50 National Institute on Aging AgePage Cancer Facts for People Over 50 Cancer strikes people of all ages, but you are more likely to get cancer as you get older, even if no one in your family has ever had

More information

RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015.

RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. AIMS AND OBJECTIVES OF THE NEXT ½ HOUR. Brief overview of the different types of gynaecological cancers

More information

CANCER. Mrs. Davis Health Education

CANCER. Mrs. Davis Health Education CANCER Mrs. Davis Health Education Cancer Terms: Tumors: Masses of useless tissue Benign: Non-cancerous Malignant: Cancerous Metastasis: Spread of cancer from the point where it originated to other parts

More information

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network

More information

Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden

Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden 2018-11-16 Nordiskt möte Diagnostiska Centrum Cancer diagnosis

More information

Temozolomide Chemotherapy -

Temozolomide Chemotherapy - n The Leeds Teaching Hospitals NHS Trust Temozolomide Chemotherapy - instructions for taking during your radiotherapy for a primary brain tumour Information for patients This information is for patients

More information

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine. Bendamustine Bendamustine This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back,

More information

NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.)

NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.) NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.) TODAY'S DATE Your age DATE OF BIRTH YOUR NAME (Last) (First) (M.I.) REFERRED HERE BY YOUR PAST MEDICAL HISTORY (If YOU have

More information

Methotrexate for inflammatory bowel disease: what you need to know

Methotrexate for inflammatory bowel disease: what you need to know Methotrexate for inflammatory bowel disease: what you need to know This leaflet aims to answer your questions about taking methotrexate for inflammatory bowel disease (IBD). If you have any questions or

More information

The treatment is given every 3 weeks for 6 to 8 cycles.

The treatment is given every 3 weeks for 6 to 8 cycles. R-CVP R-CVP This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for others it

More information

Oral cyclophosphamide in ovarian cancer

Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer Oral cyclophosphamide in ovarian cancer This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

Northumbria Healthcare NHS Foundation Trust. Laparoscopic Cholecystectomy. Issued by the Department of Upper Gastrointestinal Surgery

Northumbria Healthcare NHS Foundation Trust. Laparoscopic Cholecystectomy. Issued by the Department of Upper Gastrointestinal Surgery Northumbria Healthcare NHS Foundation Trust Laparoscopic Cholecystectomy Issued by the Department of Upper Gastrointestinal Surgery Laparoscopic Cholecystectomy This leaflet explains why you have been

More information

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Position Statement produced by BSG, AUGIS and ACPGBI GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Introduction In 2011 the Independent Practice

More information

Brentuximab vedotin. Brentuximab vedotin

Brentuximab vedotin. Brentuximab vedotin Brentuximab vedotin Brentuximab vedotin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Vinblastine (Lymphoma)

Vinblastine (Lymphoma) Vinblastine (Lymphoma) Vinblastine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

Myeloma Haematology and Transplant Unit CTD1

Myeloma Haematology and Transplant Unit CTD1 CTD1 Myeloma Haematology and Transplant Unit CTD1 This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of

More information

Gemcitabine and carboplatin (Lung)

Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) Gemcitabine and carboplatin (Lung) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may

More information

Acute Oncology Induction Training Specification

Acute Oncology Induction Training Specification Acute Oncology Induction Training Specification Author: Acute Oncology/Cancer of Unknown Primary Clinical Network Group (AO/CUP CNG) V. 2.0 Agreed: 30.11.2012 Reviewed: May 2015 Review : May 2016 MCCN

More information

North Trent Cancer Network. Referral Guidelines, Head & Neck Cancer (including Thyroid), for Primary Care Practitioners

North Trent Cancer Network. Referral Guidelines, Head & Neck Cancer (including Thyroid), for Primary Care Practitioners North Trent Cancer Network Fulwood House Sheffield S10 3TH http://nww.barnsleyhealth.nhs.uk/pct/norcom/cancer/ Tel: 0114 2263436 Fax: 0114 2263407 Email: Kim.Fell@ntcn.nhs.uk Referral Guidelines, Head

More information

Epirubicin. Epirubicin

Epirubicin. Epirubicin Epirubicin Epirubicin This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer coming back, for

More information

Patient Information Leaflet Number: CC 041 v2

Patient Information Leaflet Number: CC 041 v2 Be Cancer Aware Patient Information Leaflet Number: CC 041 v2 Increase your awareness The sooner cancer is diagnosed the easier it can be treated. Being aware of when to seek advice can make a difference.

More information

Be cancer aware Patient Information

Be cancer aware Patient Information Be cancer aware Patient Information Author ID: AMK Leaflet Number: CC 041 Version: 2 Name of Leaflet: Be cancer aware Be Date cancer Produced: aware October 2017 Page 1 of 12 Review Date: October 2019

More information